Kobo Biotech Stock Screener | Share Price & Fundamental Analysis
KOBO
Commodity Chemicals
Screen Kobo Biotech share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹2.38
▼
-0.12 (-4.80%)
Market Cap
₹5.61 Cr.
P/B Ratio
-0.04
EPS (TTM)
₹-15.47
Dividend Yield
-
Debt to Equity
3.38
52W High
₹3.93
52W Low
₹2.09
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹396.00
Total Equity
₹53.00
Kobo Biotech Share Price History - Stock Screener Chart
Screen KOBO historical share price movements with interactive charts. Analyze price trends and patterns.
Kobo Biotech Company Profile - Fundamental Screener
Screen Kobo Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for KOBO shares.
Sector
Chemicals
Industry
Commodity Chemicals
Sub-Sector
Commodity Chemicals
Segment
E
ISIN
INE881A01015
Kobo Biotech Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen KOBO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2015 |
|---|---|
| Assets | |
| Total Assets | 396 |
| Current Assets | 290 |
| Fixed Assets | 104 |
| Liabilities | |
| Total Liabilities | 396 |
| Current Liabilities | 79 |
| Non-Current Liabilities | 0 |
| Shareholders' Equity | |
| Total Equity | 53 |
| Share Capital | 23 |
| Reserves & Surplus | 31 |
Screen KOBO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2015-March |
|---|---|---|
| Revenue | 0 | 103 |
| Expenses | 0 | 104 |
| EBITDA | 0 | -1 |
| Operating Profit % | 0.00% | -1.00% |
| Depreciation | 0 | 10 |
| Interest | 0 | 24 |
| Profit Before Tax | 0 | -34 |
| Tax | 0 | 1 |
| Net Profit | 0 | -35 |
| EPS | 0.00 | -15.47 |
Kobo Biotech Cash Flow Screener - Liquidity Fundamentals
Screen KOBO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2015-March |
|---|---|
| Operating Activities | 7 |
| Investing Activities | -5 |
| Financing Activities | -13 |
| Net Cash Flow | -11 |
Screen KOBO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2024-Mar | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% | 44.95% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% | 0.66% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 48.27% | 47.70% | 47.75% | 47.86% | 47.97% | 46.81% | 46.81% | 46.65% |
| Other Holding | 6.12% | 6.69% | 6.64% | 6.53% | 6.42% | 7.57% | 7.57% | 7.74% |
| Shareholder Count | 6,767 | 6,496 | 6,458 | 6,478 | 6,530 | 5,862 | 6,064 | 6,064 |
Kobo Biotech Dividend Screener - Share Yield Analysis
Screen KOBO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Kobo Biotech Index Membership - Market Screener Classification
Screen KOBO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Kobo Biotech Market Events Screener - Corporate Actions
Screen KOBO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2020-08-17 | 2020-08-17 | Change Of Name | NA | - |
Kobo Biotech Competitors Screener - Peer Comparison
Screen KOBO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Tata Chemicals | 19,786 | 48.99 | 15,112 | -3.79% | 354 | 44.06 |
| Deepak Fertilisers & Petrochemicals | 15,808 | 15.77 | 10,355 | 17.69% | 945 | 41.57 |
| Gujarat Narmada Valley Fert & Chem | 7,191 | 11.29 | 8,393 | -0.07% | 586 | 43.68 |
| GHCL | 5,489 | 9.16 | 3,271 | -6.51% | 624 | 42.76 |
| Blue Pearl Agriventures | 5,206 | 8928.00 | 35 | 11666.67% | 1 | 42.60 |
| Chemplast Sanmar | 4,250 | -19.21 | 4,393 | 9.61% | -110 | 38.41 |
| Tanfac Industries | 4,220 | 45.02 | 560 | 45.35% | 88 | 61.61 |
| Gujarat Alkalies & Chemicals | 3,733 | 25277.50 | 4,165 | 6.89% | -65 | 38.56 |
| Thirumalai Chemicals | 2,803 | -18.50 | 2,070 | -1.54% | -46 | 46.26 |
| Fischer Medical Ventures | 2,766 | 139.10 | 112 | 421.86% | 1 | 30.07 |
Kobo Biotech Company Announcements - News Screener
Screen KOBO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors | View |
| 2025-10-30 | Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors | View |